Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...
Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. Read why HIMS stock is a ...
Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...
The 150-year-old drugmaker is the first company in health care to hit the milestone. By Rebecca Robbins Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, ...
Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after taking tirzepatide (Zepbound), showing the medication suppressed brain ...
When I walked into Zepbound’s Changing the Threads exhibit in New York City, the first thing I noticed were the clothes suspended around the space. And no, I wasn’t paying much attention to the ...
Zepbound’s Changing the Threads exhibit in Manhattan’s uber-chic Soho area was unlike anything I’d seen before. As soon as I stepped inside, I was greeted with a flood of green lights and projections.
Wegovy and Zepbound are certain to be top sellers if the federal drug marketplace is launched. The two medications, and others, are set to be priced very advantageously. Under its terms, those ...
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid. Part of a class of drugs known ...
There’s no question that medications like semaglutide (Wegovy) and tirzepatide (Zepbound) have been making headlines lately. They’re two of the few injectable medications approved specifically for ...
In a dramatic industry confrontation, pharmaceutical giant Eli Lilly is making strategic moves that could reshape market dynamics. The company announced it will transition approximately 50,000 ...
Eli Lilly’s Zepbound push is getting a “Queer Eye” makeover with the help of fashion expert Tan France, who is joining the drugmaker to knit together a collection of stories that uses clothing to ...